IPC signs MoUs with DSMNRU and CSIR-CIMAP to strengthen healthcare quality and scientific innovation

The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, Government of India, has signed and renewed two Memoranda of Understanding (MoUs) with Dr Shakuntala Misra National Rehabilitation University (DSMNRU), Lucknow, and CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) as part of its commitment to the vision of Viksit UP–Viksit Bharat.

The ceremony was attended by Prof. Sanjay Singh, Vice-Chancellor, DSMNRU, Dr V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, and senior officials from CSIR-CIMAP.

The renewed MoU with CSIR-CIMAP will continue collaboration in medicinal plant research, standardisation and quality evaluation of herbal medicines.

The new MoU with DSMNRU will focus on developing scientific protocols for assessing the quality, safety and performance of assistive devices used by persons with disabilities. The collaboration will also support the development of a pharmacovigilance training module in sign language to enhance medicine safety awareness and adverse drug reaction reporting among persons with disabilities.

Speaking on the occasion, Dr V. Kalaiselvan said that these collaborations will strengthen scientific research, quality standards and institutional partnerships, supporting Uttar Pradesh’s emergence as a centre of excellence in healthcare and pharmaceutical quality. He emphasised that such initiatives contribute directly to the shared vision of Viksit UP–Viksit Bharat by improving access to safe, effective and quality healthcare products.

According to IPC, the partnerships reaffirm its commitment to advancing quality healthcare, scientific innovation and capacity building in support of national healthcare priorities.